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684Reinfection after resection and revascularization of
infected infrarenal abdominal aortic grafts
Kristofer M. Charlton-Ouw, MD, FACS,a,b Harleen K. Sandhu, MD,a Guanmengqian Huang, MD,c
Samuel S. Leake, BS,a Charles C. Miller III, PhD,a,b Anthony L. Estrera, MD, FACS,a,b
Ali Azizzadeh, MD, FACS,a,b and Hazim J. Saﬁ, MD, FACS,a,b Houston, Tex; and Shanghai, China
Objective: Despite advances in perioperative care, long-term and amputation-free survival rates are poor after resection of
infected abdominal aortic grafts. We reviewed our cases to determine the rate of reinfection and risk factors for mortality
and limb loss.
Methods: We reviewed cases with infrarenal aortic graft infection from 1999 to 2013. Cases requiring graft excision were
included for analysis. Thoracic and thoracoabdominal aortic grafts were excluded. Reconstruction types included both
extra-anatomic and in situ grafts. Patient comorbidities, surgical outcomes, and known reinfection rates were assessed.
Univariate and Kaplan-Meier analysis were performed.
Results: Twenty-eight patients had resection of infected infrarenal abdominal aortic grafts during the study period. Most
patients (26/28; 93%) had infected aortoiliac or aortofemoral prosthetic bypass grafts, but two of 28 patients had
infected endovascular aortoiliac stent grafts. The median age was 69 years (range, 46-86 years), with 68% men and 32%
women. Aortoenteric ﬁstulae or graft-enteric erosions were noted in 12 of 28 (43%) patients at operation. There were 79%
of patients who had in situ reconstruction, including 4 (14%) with polyester, 1 (4%) with polytetraﬂuoroethylene, 3 (11%)
with cadaveric homograft, 3 (11%) with composite grafts, and 11 (39%) with native femoropopliteal vein grafts. Five
(18%) patients had extra-anatomic bypass and one had excision without revascularization. In-hospital mortality after
initial graft excision and revascularization occurred in two (7%) patients. Seven (25%) patients had evidence of reinfection
after a median of 20 months, of whom ﬁve underwent reintervention with two additional in-hospital deaths. All in-
hospital deaths occurred in patients with graft-enteric contamination. Overall limb salvage and survival at a mean
follow-up of 2.5 years were 82% and 46%, respectively, and did not differ among revascularization types (P [ .85 and
.74). One-year amputation-free survival was 47% overall. Three patients with native femoropopliteal vein graft repair
required amputation in follow-up. Diabetes was the only observed risk factor for amputation (P [ .05). Risks for
mortality included history of cerebrovascular disease (P[ .05) and shock on presentation (P[ .04). No other comorbid
condition, type of revascularization, or perioperative complication was associated with limb loss or mortality on univariate
analysis.
Conclusions: Revascularization after excision of infected abdominal aortic grafts can be done with acceptable in-hospital
morbidity and mortality. Reinfection is problematic, regardless of revascularization conduit, and is associated with limb
loss and death. New and aggressive local anti-infective strategies are warranted. (J Vasc Surg 2014;59:684-92.)Infrarenal abdominal aortic graft infection is un-
common but can lead to limb loss or death. Since the
1980s, improvements in perioperative care and surgical
technique have improved limb salvage and early mortality
from 50% to less than 15%.1,2 Although small series report
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://dx.doi.org/10.1016/j.jvs.2013.09.030long-term results.5,6 Debridement of dead tissue, repair
of graft-enteric erosions, and systemic antibiotics with or
without graft excision are the mainstays of treatment.
Regardless of revascularization technique, the long-
term outcomes after repair of infected abdominal grafts
are poor, with 5-year mortality rates ranging from 30% to
60%.1,7,8 Compared with contemporary, noninfected
open bypass cases with long-term mortality rates of 9% to
24%,9-11 aortoiliac revascularization after infected graft
excision clearly has lower survival and limb salvage. In
the absence of pathological studies, reinfection is likely
underreported and may be responsible for adverse,
midterm outcomes. We sought to determine the rate of
reinfection and identify risk factors for occurrence as well
as factors associated with mortality and limb loss.
METHODS
The Committee for the Protection of Human Subjects,
the local institutional review board, approved the study.
We retrospectively reviewed our database for cases of
infrarenal abdominal aortic graft infection admitted
between 1999 and 2013. Isolated iliac, infrainguinal,
Fig 1. Comparison over time of microbiology from infected graft
cases including blood and perigraft cultures. Numbers in bars indi-
cates number of positive cultures with percentages just outside of
bars. Anae, Anaerobic; Enterob, Enterobacter spp.; Gmþve, gram-
positive; Gmve, gram-negative; Kleb, Klebsiella spp.; MRSA,
methicillin-resistant Staphylococcus aureeus; Pseud, Pseudomonas spp.;
SSNA, Staphlococcus spp. non-aureus; Strep/entero, Enterococci and
Streptococci.
Table II. Microbiology culturesa
Organisms cultured
Blood, perigraft ﬂuid,
and wound
cultures, No. (%)
Graft only,
No. (%)
Gram-positive 30 (44) 14 (38)
Enterococci and
Streptococci
8 þ 2 ¼ 10 (15) 4 (11)
Staphylococcus non-aureus 10 (15) 5 (14)
Methicillin-resistant
S. aureus
5 þ 1 ¼ 6 (9) 1 (3)
Vancomycin-resistant
Enterococci
4 (6) 4 (11)
Gram-negative 25 (37) 14 (38)
Klebsiella spp. 4 þ 3 ¼ 7 (10) 2þ 1 ¼ 3 (8)
Enterobacter spp. 5 (7) 5 (14)
Pseudomonas spp. 4 (6) 2 (5)
E. coli 3 þ 1 ¼ 4 (6) 3 (8)
Anaerobes 3 þ 1 ¼ 4 (6) 3 (8)
Fungus 9 (13) 6 (16)
Total 68 37
aThe numbers are inclusive of reintervention cultures written in italics.
Table I. Patient demographics and initial presentation
Variable Patients, No. (%)
All patients 28
Age, years (mean [range]) 69 (46-86)
Gender
Males 19 (68)
Females 9 (32)
Ethnicitya
African American 21 (78)
Caucasian 4 (15)
Other 2 (7)
Comorbidities
Coronary artery disease 14 (50)
Hypertension 24 (86)
Hyperlipidemia 15 (54)
Chronic obstructive pulmonary disease 15 (54)
Smoking 26 (96)
Prior AAA 18 (64)
Prior aortoiliac occlusive disease 10 (36)
Cerebral vascular disease 10 (36)
Previous renal disease 8 (29)
Presentation
Sepsis (fever, leukocytosis, bacteremia) 27 (96)
Bleeding 17 (61)
Shock 5 (18)
Pain 19 (68)
Pseudoaneurysm 5 (18)
Enteric contamination at presentation 12 (43)
Previous aortic reconstruction
Aorto-fem (uni/bifemoral) 21 (75)
Tube and/or aortoiliac 5 (18)
Endovascular repair 2 (7)
AAA, Abdominal aortic aneurysm.
aOne patient’s ethnicity is unknown.
JOURNAL OF VASCULAR SURGERY
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extent IV, were excluded from review. In at least two cases
during the study period, including a patient with aortoduo-
denal ﬁstula and massive hematemesis, death occurredbefore operative intervention and before consultation by
our service. These cases were not included for analysis.
Clinical presentation, microbial culture data, radiologic
imaging, and intraoperative ﬁndings determined the diag-
nosis of graft infection. In most cases, the index operation
was performed outside of our service, but we obtained
information about the original surgery whenever possible.
Cases were categorized according to indication, either
aneurysm or aortoiliac occlusive disease.
We used a modiﬁed Bunt’s classiﬁcation12 to describe
the types of graft infection. Early-onset graft infection
was deﬁned as occurring within 4 months of initial surgery.
Infections involving the intra-abdominal portion of the
graft were deﬁned as P0. Infections involving the femoral
limbs in the groin, but without evidence of involvement
of the intra-abdominal portion of the graft, were classiﬁed
as P2. Patients classiﬁed as having aorto- or graft-enteric
ﬁstulae and erosions had pathologic conﬁrmation at opera-
tion. Although the pathology of ﬁstulas is somewhat
different from prosthetic graft erosion into the bowel
Fig 2. Flowchart of management and reinfection of infected graft cases. PTFE, Polytetraﬂuoroethylene.
Table III. Neo-aortoiliac system (NAIS) outcomes
Pt
No.
Original graft
conﬁguration 10 Etiology Bunt’s class
Enteric
connection
Infected
graft repair Reinfection Reintervention Amputation Death
1 ABF AAA P0 X NAIS X X X X
2 ABF AAA GEE O NAIS þ enteric repair O O X O
3 ABF AAA P0 X NAIS X X X O
4 ABI AAA P0 X NAIS O X X X
5 Tube graft AAA P0 X NAIS X X X O
6 ABI AAA P0 X NAIS X X O O
7 ABF AAA P0 X NAIS X X X O
8 ABF AAA GEE O NAIS þ enteric repair X X O X
9 ABF AAA P0 X NAIS X X X X
10 ABF AIOD P2 X NAIS O O O X
11 L AF AAA P2 X NAIS X X X X
AAA, Infrarenal abdominal aortic aneurysm; ABF, aortobifemoral; ABI, aortobiiliac; AIOD, aortoiliac occlusive disease; GEE, graft-enteric erosion; L AF, left
axilounifemoral.
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the purpose of analysis. Postoperatively, these patients were
treated differently from patients without enteric contami-
nation since their antibiotics were generally not tailored
to a speciﬁc organism, despite isolated growths on microbi-
ologic culture medium. We assumed the presence of poly-
microbial enteric organisms, including anaerobes and
fungus.
All patients were given a course of postoperative antibi-
otics. The speciﬁc antibiotic combination and duration was
determined by infectious disease consultants. The duration
of postoperative antibiotic therapy ranged from at least
6 weeks to others who were recommended to have life-
long daily antibiotics. Social workers and case managers
identiﬁed community resources for patients with inade-
quate insurance. In addition, the hospital system allocated
funding in order to facilitate outpatient antibiotic therapy.All patients and transfer requests within our catchment area
were accepted for treatment, regardless of insurance status.
Long-term follow-up for survival analysis was obtained
from hospital charts, ofﬁce visits, and records. The Nation-
al Social Security Death Index registry was utilized to sup-
plement mortality data in ofﬁce records wherever
required. Our primary outcomes were overall survival and
amputation-free survival. Our secondary outcome was
aortic graft reinfection.
Surgical technique. All patients received systemic
antibiotics, infected graft excision, and local debridement
of devitalized tissues via midline laparotomy. The choice
of reconstruction was per the surgeon and patient. Recon-
structions included in situ and extra-anatomic bypasses. For
extra-anatomic repairs, patients had axillobifemoral by-
passes before infected graft excision, either during the
same operative setting or the day before. For patients with
Fig 3. Computed tomography image of infected aortoiliac
endograft with aortoduodenal ﬁstula. There is air within the aortic
wall surrounding the iliac limbs.
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system (NAIS), the superﬁcial femoral veins were dissected
free prior to infected graft excision, either during the same
operative setting or the day before. Most patients required
supraceliac clamping for excision of the infected graft and
debridement of the aortic stump. Intraoperative cell salvage
was used at the surgeon’s discretion but always after excision
of the infected graft and repair of enteric connections. Our
management of duodenal ﬁstulae and erosions evolved. We
previously performed duodenal mobilization with primary
repair and, rarely, with exclusion and diversion.
Currently, we leave the duodenum in place and
perform primary repair. The repair is reinforced with a pedi-
cled omental ﬂap as a Graham patch. This also serves toFig 4. Images of infected aortoiliac endograft with aortodu
toiliac endograft with evidence of aortoduodenal ﬁstula. B
aortoduodenal ﬁstula. C, Completed repair of aortoduodenal
iliac Dacron graft. The graft was soaked with rifampin solutibuffer the duodenum from the new in situ aortic graft.
Even without enteric connections, most patients have
adjunctive procedures, such as omental ﬂap envelopment
of the new graft or the aortic stump and sartorius muscle
ﬂaps in the groins, as needed. Patients also have soaking
of new prosthetic grafts in rifampin solution, placement
of antibiotic beads, and/or repeated washouts with open
abdomen and negative-pressure wound therapy.
Statistical analysis. Univariate analysis was performed
separately for mortality, amputation, reinfection, and rein-
terventions as the dependent variables. All demographic,
clinical, comorbid, treatment-related, in-hospital, and late
complication variables were tested as independent variables.
c2 analysis or Fisher exact test was performed for differences
between categorical variables. Differences in means for the
analysis of continuous variables were assessed by Student t-
test or Mann-Whitney U test when normality assumption
was not met. Relationships between variables were assessed
by correlation and regression analysis. To analyze the
inﬂuence of each covariate on long-term survival, Kaplan-
Meier survival estimates were performed. Any statistically
signiﬁcant association was deﬁned based on the P value
elicited by log-rank test and Wilcoxon test between group
and subgroup comparisons. A P value of #0.5 was consid-
ered statistically signiﬁcant. No attempt was made to impute
missing data. Statistical computations were performed using
STATA 12.1 (StataCorp, College Station, Tex).
RESULTS
We identiﬁed 30 patients during the 14-year study
period. Two presented in extremis and died en route
before initiation of surgery. They were, therefore, excluded
from further analysis. In the remaining 28 patients, the
median age was 69 years (range, 46-86 years), with 19
men and nine women. Patient demographics, pre-existing
comorbidities, and characteristic presentation on admission
are summarized in Table I. The indication for the index
aortic repair was aneurysm in 18 (64%) and occlusive
disease in 10 (36%). The mean duration between original
graft implantation and presentation with graft infectionodenal ﬁstula. A, Computed tomography image of aor-
, Intraoperative image of opened infrarenal aorta with
ﬁstula, excision of infected endograft, and in situ aortobi-
on and covered with pedicled omental ﬂap.
Table IV. Reinfection patients
Original graft 10 etiology 10 cultures First reconstruction Time to reinfection
1 ABF þ Fem-pop (Dacron) AAA Enterobacter, SSNA,
Prevotella, Candida,
Anaerobic gram-neg. rods
NAIS þ AEF repair 2 weeks
2 ABF (Dacron) AIOD Negative ABF (homograft) 1.6 months
3 ABI (Dacron) AAA Group C beta-hemolytic
Streptococcus, SSNA
NAIS 1 month
4 ABF (DacronþPTFE) AIOD Group B Streptococcus,
Candida albicans. Post-op
wound/groin -
Enterococcus, SSNA,
Corynebacterium, Prevotella
spp.
ABF with PTFE left obturator
canal aortofemoral bypass
4.5 years
5 ABI þ Fem-fem
(DacronþPTFE)
AAA VRE, Pseudomonas, Klebsiella
pneumoniae, E. coli
Left axillofemoral PTFE 1 year
6 ABF þ Fem-pop (Dacron) AIOD Negative ABF (Dacronþhomograft) 2.8 years
7 ABF (Dacron) AIOD Morganella morganii, SSNA NAIS 3 months
AAA, Abdominal aortic aneurysm; ABF, aortobifemoral bypass; ABI, aortobi-iliac bypass; AEF, aortoenteric ﬁstula; AIOD, aortoiliac occlusive disease;
Fem-fem, femorofemoral bypass; Fem-pop, femoropopliteal bypass; MRSA, methicillin-resistant Staphylococcus aureeus; NAIS, neoaortoiliac system; PTFE,
polytetraﬂuoroethylene; SSNA, Staphlococcus spp. non-aureus; VRE, vancomycin-resistant Enterococcus.
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(<4 months after index surgery) occurred in 24%.
Based on the modiﬁed Bunt’s classiﬁcation, 20 (71%)
patients had P0 infections involving the intracavitary graft
portion and eight (29%) had P2 infections restricted to
the groin. Of these, eight (29%) were graft-enteric erosions
and four (14%) were aorto/graft-enteric ﬁstulae. Infected
graft conﬁgurations were aortobifemoral in 21 (75%), aor-
toiliac or aortic tube graft in 5 (18%), and endovascular
aortoiliac stent grafts in 2 (7%). Five (24%) of the aortobi-
femoral patients presented with infected groin pseudoa-
neurysm, of which one also had contamination of the
abdominal portion of the graft.
The most common presentation was constitutional
signs and symptoms of infection, including fever, chills,
and leukocytosis, reported in 27 (96%) patients. Pain was
the second-most common symptom, occurring in 19
patients (68%). Patients with graft-enteric connections
tended to present more dramatically, including bleeding
(75%) and shock (33%). No patient comorbid condition
was associated with the occurrence of enteric connection
at presentation but in at least two patients, we could ﬁnd
no attempt to exclude the graft from the bowels at the index
operation (eg, no omental ﬂap, aneurysm sac, or retroperi-
toneal tissue coverage). In other words, the bowels were
placed directly in contact with the prosthetic graft.
Microbiology. Microbiological data were obtained in
100% patients, of whom 23 (82%) had positive and ﬁve
(18%) had negative pre- and intraoperative cultures. The
most common species isolated in culture was Staphylococcus
non-aureus followed by Klebsiella spp. The summary of
microbiological cultures is provided in Table II. Of the
68 total microbiological specimens, gram-positive organ-
isms grew in 44%, gram-negative in 37%, anaerobes in 6%,
and fungus in 13%. Most patients with enteric connections
were noted to have more virulent strains on culture. In 10of 12 (83%) enteric contamination cases, cultures showed
drug-resistant bacteria and difﬁcult-to-treat organisms,
such as Pseudomonas, Morganella, Serratia, and fungus.
We noted gram-positive organisms in both early and late
infections, but there were fewer gram-negative (P ¼ .06),
anaerobic (P ¼ .69), and fungal organisms (P ¼ .65) in
early infections. An analysis of the microbial spectrum over
the last 14 years showed a decreasing trend in gram-
positive infections and an increase in gram-negative and
fungal infections (Fig 1), but this may be reﬂective of the
relatively high incidence of graft-enteric erosions.
Operative management. A total of 33 graft excisions
were performed, with 28 occurring at presentation and ﬁve
additional major reinterventions performed due to reinfec-
tion. There were 30 revascularizations, with 27 occurring
at presentation and three during reintervention for reinfec-
tion (Fig 2). One patient had graft excision without
revascularization at presentation. The average of blood
products transfused were 2.4 units of cell salvage, 2.8 units
platelets, 3.7 units fresh frozen plasma, and 9.8 units of
packed red blood cells.
The one patient who was not revascularized after
infected graft excision was a 70-year-oldmale who presented
with gastrointestinal bleeding and hemorrhagic shock.
At emergency operation, he had an infected end-to-side aor-
tobifemoral bypass with graft-enteric ﬁstula at the prox-
imal anastomosis. Given his hemodynamic instability,
acidosis, and coagulopathy, he had repair of the jejunal
ﬁstula and excision of the infected graft, but lower
extremity revascularization was deferred. He had bilateral
Doppler pedal signals after graft excision. He suffered
multiorgan dysfunction, including respiratory and renal
failure. He survived to discharge but died a month later
at a long-term care facility.
Extra-anatomic bypasses were performed in ﬁve
patients, and in situ reconstruction was done in 22
Course 20 cultures Second reconstruction Amputation Death (from reintervention)
Reinfection and NAIS
disruption
Negative Axillobifemoral PTFE X 8 months
Wound/groin reinfection
medically managed
Negative X X N/A
Reinfection medically
managed
SSNA X X N/A
Reinfection and left groin
pseudoaneurysm
MRSA, Morganella morganii,
Group D Streptococcus,
Klebsiella oxytoca,
Enterococcus
Left graft limb excision
without reconstruction
O 6 years
Reinfection and aortic stump
blowout
E. coli, K. pneumoniae,
Anerobic gram-neg. rods
Left axillofemoral PTFE X In-hospital
Reinfection, AEF, and
pseudoaneurysm
Klebsiella pneumoniae ABF (Dacron) O In-hospital
Reinfection and left groin
pseudoaneurysm
Negative ABF (Dacron) O N/A
Table IV. Continued
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 3 Charlton-Ouw et al 689patients at presentation. Extra-anatomic bypasses were with
axillobifemoral prosthetic grafts, and all were performed in
patients with graft-enteric connections. In the 22 in situ
reconstructions, the conduits included 4 polyester
(Dacron), 3 cadaveric homograft, 1 polytetraﬂuoroethy-
lene (PTFE), 3 composite grafts (1 homograft/autogenous
vein, 1 homograft/Dacron, and 1 PTFE/Dacron), and 11
NAIS (Table III).
Two patients had endovascular stent grafts with aor-
toenteric ﬁstulae. The ﬁstulae were between the duodenum
and native infrarenal aortic wall, and neither stent graft was
directly in contact with the bowel. One patient had stent
grafting with a polyester modular aortoiliac device. His
postoperative course was complicated by colon ischemia
requiring colectomy. Two months later, he was transferred
to us with massive gastrointestinal bleeding (Fig 3). The
other patient had fevers and iliac limb thrombosis after
stent grafting with unibody bifurcated PTFE device
(Fig 4, A and B). Both patients had new type 1 endoleak
and had stent graft excision with in situ reconstruction
with Dacron aortobiiliac bypass grafting (Fig 4, C).
Reinfection. Seven patients had evidence of reinfec-
tion over median follow-up of 6.0 years (interquartile
range, 1.1-10.8 years; Table IV). A comparison of patients
with reinfection to those without reinfection is shown in
Table V. Patients with reinfection were younger (P ¼ .03)
and had a higher incidence of anaerobic organisms cultured
at their initial graft replacement (odds ratio, 15; 95%
conﬁdence interval, 1.7-131.0; P ¼ .01). Other comor-
bidities, including diabetes and smoking, did not appear to
affect the incidence of reinfection.
Among reinfection patients, three patients had their
initial repair with NAIS, one had axillofemoral bypass,
one had cadaveric homograft, and the remaining two had
in situ prosthetic composite aortobifemoral grafts. One of
the patients who had NAIS reconstruction was readmitted2 weeks later with reinfection and femoral limb vein graft
disruption (Table III). The patient was managed with
emergency excision of the femoropopliteal vein graft limb
and replacement with axillounifemoral bypass. His initial
intraoperative cultures grew Enterobacter aerogenes. The
cultures on reintervention showed no growth. The patient
died 8 months later from unknown causes. A second NAIS
patient had recurrent groin infection that required repeated
incision and drainage procedures until he returned with
a left groin pseudoaneurysm 3 months after the reconstruc-
tion procedure. His cultures grew Morganella morganii.
The patient underwent primary repair of the pseudoaneur-
ysm with debridement. Eight months later, the patient had
a left leg amputation at an outside hospital. A third NAIS
patient was readmitted 1 month after repair with copious
right groin wound drainage, fevers, and mental status
changes. His right groin wound was reopened, and he
was kept on life-long oral antibiotics by infectious disease
consultants. It is unclear if the infection remained superﬁ-
cial or involved the graft limb.
Of the two patients with prosthetic in situ repairs who
had reinfection, one was readmitted 3 years after repair
with composite (homograft þ Dacron) aortobifemoral
graft. At reoperation, there was graft-enteric erosion and
groin pseudoaneurysm. The patient was managed with
graft resection and replacement with a Dacron aortobife-
moral graft, but the patient succumbed to multiorgan
dysfunction, hypoxic/ischemic encephalopathy, and hemo-
dynamic instability on the second postoperative day. The
other reintervention patient with prosthetic in situ repair
had a composite (Dacron þ PTFE) aortobifemoral graft
with one (PTFE) limb tunneled through the left obturator
canal due to groin infection. The obturator canal limb
became reinfected, and the patient returned with groin
pseudoaneurysm 4.5 years after repair. The patient under-
went excision of the left obturator canal segment of the
Table V. Comparison of patients with reinfection and
without reinfection
Patient variable
Reinfection,
No. (%)
No
reinfection,
No. (%) P value
All patients 7 (25) 21 (75) -
Age, years (mean [range]) 57 (46-78) 69 (48-86) .034
Females 3 (33) 6 (67) -
Ethnicitya .165
African American 4 (19) 12 (75)
Caucasian 2 (50) 2 (50)
Other 1 (50) 2 (13)
Modiﬁed Bunt’s Classiﬁcation
1 2 (25) 6 (75) .667
2 3 (38) 5 (63)
3 2 (83) 10 (83)
Comorbidities
Coronary artery disease 5 (36) 9 (64) .199
Hypertension 6 (25) 18 (75) 1.00
Dyslipidemia 4 (27) 11 (73) .829
Chronic obstructive
pulmonary disease
2 (13) 13 (87) .662
Diabetes 3 (50) 3 (50) .117
Smoking 6 (23) 20 (77) .259
Prior AAA 3 (17) 15 (83) .179
Prior aortoiliac occlusive
disease
4 (40) 6 (60) .179
Cerebral vascular disease 1 (10) 9 (90) .127
Previous renal disease 1 (13) 7 (88) .311
Cultures .608
Negative 2 (40) 3 (14)
Single organism 1 (11) 8 (89)
Polymicrobial 4 (29) 10 (71)
Gram-positive 5 (26) 14 (74) .819
Gram-negative 4 (29) 10 (71) .668
Anaerobe 3 (75) 1 (25) .014
Fungal 2 (25) 6 (75) 1.00
Presentation
Sepsis (fever, leukocytosis,
bacteremia)
7 (26) 20 (74) 1.00
Bleeding 5 (29) 12 (71) .510
Shock 2 (40) 3 (60) .401
Pain 6 (32) 13 (68) .251
Pseudoaneurysm 1 (20) 4 (80) .779
Aortoenteric ﬁstula 2 (17) 10 (83) .387
Previous aortic reconstruction .771
Aortofemoral bypass
(uni/bifemoral)
5 (24) 16 (76)
Tube graft and/or
aortoiliac bypass
2 (40) 3 (60)
Endovascular repair 0 (0) 2 (100)
AAA, Abdominal aortic aneurysm.
aAfrican American was used as the reference category for odds of Caucasians
and other ethnicity categories.
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patient developed acute limb ischemia, and a below-knee
amputation was performed. Another patient who had
extra-anatomic bypass had an aortic stump blowout and
retroperitoneal sepsis 1 year after repair. The patient was
managed with aortic re-debridement and emergency thor-
acofemoral reconstruction with Dacron graft. However,
the patient died 1 month after the reintervention with
persistent retroperitoneal sepsis.One reinfection patient initially presented with Dacron
aortobifemoral and bilateral femoropopliteal artery by-
passes. She had chronic right groin wound infection (Szila-
gyi III, Bunt P2) with right aortofemoral limb and right
femoropopliteal bypass thrombosis. Her aortobifemoral
and right femoropopliteal bypass grafts were excised and
replaced with cadaveric homograft bypasses. Two weeks
later, she was readmitted with rethrombosis of the right
lower limb bypasses. During the hospital readmission, she
had a right ischemic stroke with hemorrhagic conversion
requiring hemicraniotomy. She was eventually transferred
to a rehabilitation facility with left hemiparesis but was
readmitted 1 month later with right forefoot and heel
gangrene. Her right groin and leg wounds were separated
with necrotic edges. She was started on antibiotics for sus-
pected reinfection. She had bedside superﬁcial wound
debridement with negative-pressure dressing placement.
The patient was transferred back to a rehabilitation facility
and was lost to follow-up.
Outcomes. Outcomes by reconstruction technique are
summarized in Table VI. In-hospital mortality occurred in
two patients (7%) after initial infected graft excision. The
mean length of postoperative hospital stay was
25 614 days (range, 3-66 days). The mean length of
intensive care unit stay was 13.7 days. Complications and
mortality data are summarized in Table IV. Suspected
reinfection occurred in seven (25%) patients over the study
period. There was no apparent difference in primary
outcome between extra-anatomic and in situ repairs (P ¼
1.0). There was no difference between prosthetic and
autogenous conduits or in mortality between early and late
graft infections (P ¼ .12).
Eleven patients had groin wound infection, including
eight presenting with isolated groin pseudoaneurysm (Szi-
lagyi III, Bunt P2). There was no statistical difference in
amputation (P ¼ .55), reinfection (P ¼ .66), or mortality
(P ¼ .89) based on Bunt’s classiﬁcation of infection extent.
Five (18%) patients required amputation, including three
with NAIS (Table III). Of the seven cases of known rein-
fection, ﬁve had major reinterventions with two additional
in-hospital deaths. All cases of in-hospital mortality had
graft-enteric erosions or ﬁstulae.
Most patients (64%) were discharged to skilled nursing
or other comparable care facilities. Only 29% were dis-
charged to home. Long-term overall survival and
amputation-free survival rates are summarized in Fig 5, A
and B. Comparative 3-year survival based on type of revas-
cularization was 52% for in situ prosthetic, 55% for in situ
autogenous, and 60% for extra-anatomic bypasses. The 3-
year survival rates for patients with and without enteric
connections were 33% and 53% (P ¼ .31). Overall 5-
year, graft-related mortality occurred in 11 of 28 (39%)
patients. The 5-year all-cause mortality was 54%.DISCUSSION
Considered by some to be the practice standard, extra-
anatomic bypass with infected graft excision has 5-year
Fig 5. A, Kaplan-Meier curve of overall 5-year survival. B,
Kaplan-Meier curve of amputation-free 1-year survival.
Table VI. Outcomes after infected graft excision and
reconstruction
Extra-
anatomic
(n ¼ 5),
No. (%)
In situ
autogenous
(n ¼ 11),
No. (%)
In situ
prostheticb
(n ¼ 11),
No. (%)
Total
(N ¼ 28),
No. (%)
P
value
Graft excision
(n ¼ 28)a
5 11 11 -
Complications
(<30 days)
Respiratory 4 (80) 7 (64) 4 (36) 16 (57) .288
Gastrointestinal 2 (40) 2 (18) 2 (18) 7 (25) .349
Neurological 0 (0) 5 (46) 2 (18) 8 (29) .111
Renal 3 (60) 3 (27) 4 (36) 11 (39) .352
Cardiac 1 (20) 1 (9) 2 (18) 5 (18) .280
Sepsis 3 (60) 9 (82) 5 (46) 18 (64) .340
Limb ischemia 0 (0) 3 (27) 4 (36) 8 (28) .236
Venous
thrombosis
0 (0) 2 (18) 0 (0) 3 (11)a .073
Early
amputation
0 (0) 2 (18) 0 (0) 2 (7) .680
Bleeding 0 (0) 2 (18) 1 (9) 3 (11)a NS
In-hospital
mortality
1 (20) 0 (0) 1 (9) 2 (7) .680
Amputation 0 (0) 3 (27) 2 (18) 5 (18) .846
Reinfection 1 (20) 3 (27) 3 (27) 7 (25) NS
Reintervention 1 (20) 2 (18) 2 (18) 5 (18) NS
One-year
graft-related
mortality
2 (40) 4 (36) 2 (18) 9 (32) .422
Five-year
graft-related
mortality
3 (60) 4 (36) 3 (27) 11 (39) .352
Overall mortality 3 (60) 5 (46) 6 (55) 15 (54) .742
PTFE, Polytetraﬂuoroethylene.
aOne patient who did not undergo reconstruction had venous and bleeding
complications.
bFor the this comparison, prosthetic grafts included polyester, PTFE,
cadaveric homograft, and nonautogenous composite grafts.
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44% to 60%.7,13 The 5-year amputation rate after NAIS
reconstruction was 4% to 11% with mortality of 30% to
48%.8,14 For in situ cadaveric arterial homograft, the re-
ported 3- and 5-year mortality rates are 33% and 36%,
respectively.15,16 For silver-impregnated grafts (not avail-
able in the U.S.), the reported 3-year mortality rate is
38%.17 A meta-analysis suggested that outcomes were
similar among the different in situ conduits but poorer
for extra-anatomic reconstructions.18
Our results mirror the published results in the litera-
ture. The exceptions were a higher-than-expected reinfec-
tion (27%) and amputation rate (27%) than previously
reported for NAIS reconstructions. We classiﬁed patients
as reinfection even without evidence of graft reinvolve-
ment. One of the NAIS patients had groin reinfection
and was treated with superﬁcial debridement and antibi-
otics. It remains unclear if the graft was involved. We do
not have an explanation for our higher NAIS reinfection
rate, although our in-hospital mortality (0%) and 5-year
survival rates (55%) for NAIS are within the benchmarks
established in larger series.14There is increasing experience with graft preservation
techniques based on the extent of infection.6,19 We gener-
ally chose not to use graft preservation techniques in our
patient population, although some authors have shown
reasonable results in selected patients.20 Our patients
mostly presented with late infection (79%), had a relatively
high rate of intracavitary infection (79%) with enteric
contamination (43%), and generally required a more
aggressive surgical approach. Graft preservation may play
a larger role in the future if techniques to sterilize the peri-
graft tissues are established.
Although our initial survival rates are reasonable after
initial infected graft excision (93%), the long-term
mortality and reinfection rates are increased compared
with noninfection bypass cases. Graft-enteric erosions and
aorto/graft-enteric ﬁstulae carry the worst prognosis
regarding in-hospital and long-term survival. Reinfection
portends a poor outcome with many patients requiring
amputation or dying in follow-up. Four of seven patients
with reinfection survived more than 5 years after repair,
and two of the survivors eventually required leg
amputation.
A limitation of this study is the lack of systemic antibi-
otic standardization. All patients were recommended to
have at least 6 weeks of antibiotics, but some had 6 months
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disease consultant. We could not be sure how many
patients complied with the recommended antibiotic
course. Another limitation is the heterogeneity in our
patient population and the surgical reconstruction tech-
niques. The different techniques and conduit choices in
our experience reﬂects our belief that no one conduit or
method is entirely superior over another. Selection bias is
inherent. For example, no unstable patient had NAIS
reconstruction due to the length of the procedure.
Conversely, many patients in extremis had in situ recon-
struction with polyester graft since it is the most available
and expedient.
It is difﬁcult to account for the different patient presen-
tations, infecting organisms, and such selection bias. There-
fore, we cannot deﬁnitively recommend one conduit or
revascularization method over another from this study
alone. Vascular surgeons should be familiar with the
different techniques for managing infected abdominal
grafts and proﬁcient in at least a few.12 There does not
appear to be an advantage of one type of revascularization
method or conduit over another for all cases. The speciﬁc
repair technique should depend on the patient condition
and surgeon experience. We found reinfection to be prob-
lematic, regardless of conduit or technique.
CONCLUSIONS
Revascularization after excision of infected abdominal
aortic grafts can be done with acceptable in-hospital
morbidity and mortality. Reinfection is problematic,
regardless of revascularization conduit, and is associated
with limb loss and death. Our results of surgical treatment
of infrarenal abdominal aortic graft infection show that,
regardless of the technique or conduit used, long-term
survival rates are diminished and may be due to late reinfec-
tion. New and aggressive local anti-infective strategies are
warranted.
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